NYSE:ACH • US6907321029
The current stock price of ACH is 2.37 USD. In the past month the price decreased by -5.18%.
ChartMill assigns a technical rating of 3 / 10 to ACH.
ChartMill assigns a fundamental rating of 3 / 10 to ACH. ACH has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months ACH reported a non-GAAP Earnings per Share(EPS) of 1.29. The EPS decreased by -22.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.21% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
12 analysts have analysed ACH and the average price target is 3.77 USD. This implies a price increase of 59.24% is expected in the next year compared to the current price of 2.37.
For the next year, analysts expect an EPS growth of -31.69% and a revenue growth -74.09% for ACH
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 21.86 | 116.756B | ||
| COR | CENCORA INC | 19.09 | 71.14B | ||
| CAH | CARDINAL HEALTH INC | 19.98 | 52.771B | ||
| HSIC | HENRY SCHEIN INC | 15.2 | 9.617B | ||
| AHCO | ADAPTHEALTH CORP | 9.98 | 1.427B | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 28.148M |
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Accendra Health, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 13,500 full-time employees. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. The company offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.
ACCENDRA HEALTH INC
10900 Nuckols Road, Suite 400
Glen Allen VIRGINIA 100082 US
CEO: Lu Dongliang
Employees: 13500
Phone: 18042774304
Accendra Health, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 13,500 full-time employees. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. The company offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.
The current stock price of ACH is 2.37 USD. The price decreased by -0.42% in the last trading session.
ACH does not pay a dividend.
ACH has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ACH.
ACCENDRA HEALTH INC (ACH) currently has 13500 employees.
ACCENDRA HEALTH INC (ACH) will report earnings on 2026-02-19, after the market close.